Orexo Management
Management criteria checks 2/4
Orexo's CEO is Nikolaj Sorensen, appointed in Feb 2013, has a tenure of 9.75 years. total yearly compensation is SEK9.85M, comprised of 36.7% salary and 63.3% bonuses, including company stock and options. directly owns 0.28% of the company’s shares, worth SEK1.79M. The average tenure of the management team and the board of directors is 3.8 years and 3.1 years respectively.
Key information
Nikolaj Sorensen
Chief executive officer
kr9.9m
Total compensation
| CEO salary percentage | 36.7% |
| CEO tenure | 9.8yrs |
| CEO ownership | 0.3% |
| Management average tenure | 3.8yrs |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -kr152m |
| Jun 30 2022 | n/a | n/a | -kr177m |
| Mar 31 2022 | n/a | n/a | -kr216m |
| Dec 31 2021 | kr10m | kr4m | -kr223m |
| Sep 30 2021 | n/a | n/a | -kr207m |
| Jun 30 2021 | n/a | n/a | -kr240m |
| Mar 31 2021 | n/a | n/a | -kr198m |
| Dec 31 2020 | kr9m | kr3m | -kr84m |
| Sep 30 2020 | n/a | n/a | kr4m |
| Jun 30 2020 | n/a | n/a | kr201m |
| Mar 31 2020 | n/a | n/a | kr288m |
| Dec 31 2019 | kr6m | kr3m | kr219m |
| Sep 30 2019 | n/a | n/a | kr232m |
| Jun 30 2019 | n/a | n/a | kr182m |
| Mar 31 2019 | n/a | n/a | kr178m |
| Dec 31 2018 | kr5m | kr3m | kr138m |
| Sep 30 2018 | n/a | n/a | kr113m |
| Jun 30 2018 | n/a | n/a | kr79m |
| Mar 31 2018 | n/a | n/a | kr32m |
| Dec 31 2017 | kr6m | kr4m | kr23m |
| Sep 30 2017 | n/a | n/a | kr19m |
| Jun 30 2017 | n/a | n/a | kr27m |
| Mar 31 2017 | n/a | n/a | kr29m |
| Dec 31 2016 | kr5m | kr3m | kr29m |
| Sep 30 2016 | n/a | n/a | -kr57m |
| Jun 30 2016 | n/a | n/a | -kr139m |
| Mar 31 2016 | n/a | n/a | -kr229m |
| Dec 31 2015 | kr5m | kr3m | -kr210m |
Compensation vs Market: Nikolaj's total compensation ($USD940.24K) is above average for companies of similar size in the UK market ($USD348.41K).
Compensation vs Earnings: Nikolaj's compensation has increased whilst the company is unprofitable.
CEO
Nikolaj Sorensen (50 yo)
9.8yrs
Tenure
kr9,851,000
Compensation
Mr. Nikolaj Sørensen serves as Independent Director at Bioservo Technologies AB (publ) since May 6, 2019. He is Director at Gesynta Pharma AB. He has been the Chief Executive Officer of Orexo AB since Febr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & CEO | 9.8yrs | kr9.85m | 0.28% SEK 1.8m | |
| Executive VP & CFO | less than a year | no data | no data | |
| Senior VP & Head of Operations | 3.8yrs | no data | 0.013% SEK 81.8k | |
| Investor Relations & Communications Director | no data | no data | no data | |
| Senior VP and Head of R&D | 3.8yrs | no data | 0.0082% SEK 51.9k | |
| Executive Vice President of Digital Therapeutics | 2.9yrs | no data | 0.029% SEK 185.0k | |
| Chief Medical Officer | less than a year | no data | no data | |
| President of Orexo US Inc | 9.8yrs | no data | 0.025% SEK 158.8k | |
| no data | no data | no data |
3.8yrs
Average Tenure
53yo
Average Age
Experienced Management: ORXs's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 3.6yrs | kr400.00k | 0.015% SEK 96.2k | |
| Independent Chairman of the Board | 2.6yrs | kr1.50m | 0.081% SEK 518.0k | |
| Independent Director | 20.8yrs | kr350.00k | 0.011% SEK 68.0k | |
| Director | less than a year | no data | no data | |
| Independent Director | 3.6yrs | kr400.00k | 0.0034% SEK 21.3k | |
| Director | less than a year | no data | no data | |
| Director | 4.6yrs | no data | no data | |
| Independent Director | 2.6yrs | kr600.00k | 0.016% SEK 101.7k |
3.1yrs
Average Tenure
59yo
Average Age
Experienced Board: ORXs's board of directors are considered experienced (3.1 years average tenure).